Charles River Proteomic Services Inc. (CRPS) has purchased Advion Biosciences Inc.'s Nanomate 100 System technology to beef up CRPS's portfolio of research services. The company says its analytical technology now includes the world's only automated chip-based nanoelectrospray system (NanoMate 100 with ESI Chip). The technology is said to improve peptide mass fingerprinting and provide new capabilities in the areas of biomarkers and protein-protein interactions. "We are exploring the advantages this new technology provides with respect to biomarker validation/discovery, post-translational modifications of proteins, and increased de novo sequencing capabilities," says John Pirro, general manager of CRPS.
- Free Whitepaper! The 5 criteria to help you select the right analytics platform for your organization.
- Free Whitepaper! Learn how to create an analytics environment that is governed, scalable and self-serve.
- Free Whitepaper! Learn how IT is evolving from producer to enabler, and fostering collaboration around analytics.